BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/28/2019 12:23:27 PM | Browse: 974 | Download: 1895
 |
Received |
|
2019-05-21 01:52 |
|
Peer-Review Started |
|
2019-05-21 06:37 |
|
First Decision by Editorial Office Director |
|
2019-06-09 00:29 |
|
Return for Revision |
|
2019-06-11 00:34 |
|
Revised |
|
2019-07-03 01:22 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2019-07-09 09:31 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2019-07-19 15:07 |
|
Articles in Press |
|
2019-07-19 15:07 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-08-28 06:21 |
|
Publish the Manuscript Online |
|
2019-08-28 12:23 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Chronic hepatitis delta: A state-of-the-art review and new therapies
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Christy Gilman, Theo Heller and Christopher Koh |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Christopher Koh, FAASLD, FACP, MD, Attending Doctor, Liver Diseases Branch, National Institute of Diabetes & Digestive & Kidney Diseases, 10 Center Drive, Building 10, Room 9B-16, MSC 1800, Bethesda, MD 20892, United States. christopher.koh@nih.gov |
| Key Words |
Hepatitis delta; Epidemiology; Treatment; ; ; |
| Core Tip |
Delta hepatitis is a progressive disease affecting millions worldwide. Current treatment options are lacking. This review focuses on the history of interferon therapy, novel therapies that have been developed and future treatment options for a possible functional cure. |
| Publish Date |
2019-08-28 12:23 |
| Citation |
Gilman C, Heller T, Koh C. Chronic hepatitis delta: A state-of-the-art review and new therapies. World J Gastroenterol 2019; 25(32): 4580-4597 |
| URL |
https://www.wjgnet.com/1007-9327/full/v25/i32/4580.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v25.i32.4580 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
